Validation and Performance Assessment of a Commercial Anti-Peroxidasin Antibody | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Validation and Performance Assessment of a Commercial Anti-Peroxidasin Antibody Isabel Brandão, Roberto Silva, Bárbara Gomes, Jorge R. Almeida, and 2 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7575209/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 21 Jan, 2026 Read the published version in Histochemistry and Cell Biology → Version 1 posted 12 You are reading this latest preprint version Abstract Peroxidasin (PXDN) is a multidomain heme peroxidase that catalyzes sulfilimine crosslinks in type IV collagen, a reaction essential for basement membrane stability. In addition to its structural role, PXDN has been implicated in oxidative stress regulation, fibrosis, and tumorigenesis. Antibody-based detection is critical for defining PXDN expression and localization, yet few commercial reagents have been rigorously validated, limiting reproducibility. Here, we assessed the specificity and performance of a commercially available anti-PXDN antibody (Abbexa, abx101906) in immunofluorescence applications. Validation was performed in formalin-fixed, paraffin-embedded human kidney tissue and a primary kidney fibroblast line under PXDN silencing and overexpression conditions. The antibody yielded reproducible labeling patterns and demonstrated specificity across cellular contexts. These findings establish abx101906 as a reliable tool for immunofluorescence-based detection of PXDN. This validation provides a foundation for future studies of PXDN biology in kidney development, disease, and potential therapeutic targeting. Antibodies Immunofluorescence Human Kidney Biopsies Kidney Fibroblasts Full Text Additional Declarations No competing interests reported. Cite Share Download PDF Status: Published Journal Publication published 21 Jan, 2026 Read the published version in Histochemistry and Cell Biology → Version 1 posted Editorial decision: Revision requested 16 Oct, 2025 Reviews received at journal 10 Oct, 2025 Reviews received at journal 08 Oct, 2025 Reviews received at journal 24 Sep, 2025 Reviewers agreed at journal 20 Sep, 2025 Reviewers agreed at journal 17 Sep, 2025 Reviewers agreed at journal 16 Sep, 2025 Reviewers agreed at journal 15 Sep, 2025 Reviewers invited by journal 15 Sep, 2025 Editor assigned by journal 11 Sep, 2025 Submission checks completed at journal 09 Sep, 2025 First submitted to journal 09 Sep, 2025 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7575209","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":518051835,"identity":"a4a20440-9c9c-4684-abcf-a25e8b7f73c5","order_by":0,"name":"Isabel Brandão","email":"","orcid":"","institution":"Instituto de Investigação e Inovação em Saúde","correspondingAuthor":false,"prefix":"","firstName":"Isabel","middleName":"","lastName":"Brandão","suffix":""},{"id":518051836,"identity":"90c0b3ac-654f-4841-8435-c2b4c5410914","order_by":1,"name":"Roberto Silva","email":"","orcid":"","institution":"Unidade Local de Saúde de São João","correspondingAuthor":false,"prefix":"","firstName":"Roberto","middleName":"","lastName":"Silva","suffix":""},{"id":518051837,"identity":"ee6fc458-18aa-491e-874f-b6951c0f4574","order_by":2,"name":"Bárbara Gomes","email":"","orcid":"","institution":"Unidade Local de Saúde de São João","correspondingAuthor":false,"prefix":"","firstName":"Bárbara","middleName":"","lastName":"Gomes","suffix":""},{"id":518051838,"identity":"4b0867f1-0ee6-4426-ac85-ccaf7d23310b","order_by":3,"name":"Jorge R. Almeida","email":"","orcid":"","institution":"Unidade Local de Saúde de São João","correspondingAuthor":false,"prefix":"","firstName":"Jorge","middleName":"R.","lastName":"Almeida","suffix":""},{"id":518051839,"identity":"4da505a1-070b-48ab-8dd8-71547ca01817","order_by":4,"name":"João Paulo Oliveira","email":"","orcid":"","institution":"Unidade Local de Saúde de São João","correspondingAuthor":false,"prefix":"","firstName":"João","middleName":"Paulo","lastName":"Oliveira","suffix":""},{"id":518051840,"identity":"f0ed3966-263e-4e2b-8736-960cb65395f8","order_by":5,"name":"Inês Soares Alencastre","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA7UlEQVRIiWNgGAWjYBACNgbmBhib8QEDAzMxWhghWniAyg3gWg7g1YTQwiZBlBY+9oONjwtq7OztpQ8fq7pRYc1gcLuB7fEHfA7jSWw2nnEsObGHLy3tds6ZdAaDOwfYDfDZwsaQ2CbN28CcwMPDY3Y7t+0wg8GNBDYJvFr4H7b/5m2ot+fh4f9WnPuPGC0SiW3MvA2HGXt4eNiYcxuI0vKwWZrn2PHEnjNsxtI5x9J5JO8cbDc4g0eLfH/ywc88NdX27D3MDz/n1FjL8d1uPvagAo8WDMDDIMHYRooGEJAABuMoGAWjYBSMAiQAABFSR1SmPf5vAAAAAElFTkSuQmCC","orcid":"","institution":"RISE-Health / Faculty of Medicine of the University of Porto","correspondingAuthor":true,"prefix":"","firstName":"Inês","middleName":"Soares","lastName":"Alencastre","suffix":""}],"badges":[],"createdAt":"2025-09-09 15:08:20","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7575209/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7575209/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1007/s00418-025-02453-7","type":"published","date":"2026-01-21T15:58:30+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":92012834,"identity":"d37092ed-e832-4753-8342-b11ff53a045c","added_by":"auto","created_at":"2025-09-23 15:56:43","extension":"tif","order_by":0,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":16945172,"visible":true,"origin":"","legend":"","description":"","filename":"Figure1.tif","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/f7d054bd2861257ccc43e111.tif"},{"id":92012822,"identity":"e7be369a-f414-4b09-8e1a-e0224ccae222","added_by":"auto","created_at":"2025-09-23 15:56:43","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":45835,"visible":true,"origin":"","legend":"","description":"","filename":"ManuscriptHCBNocodefields.docx","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/5df7fd1354b99e507738d225.docx"},{"id":92013443,"identity":"1a5a2cf0-b817-4e71-b4fc-ac58276f08f8","added_by":"auto","created_at":"2025-09-23 16:04:43","extension":"tif","order_by":2,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":5272914,"visible":true,"origin":"","legend":"","description":"","filename":"Figure2.tif","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/55b3b3942e2275a12d0ccec9.tif"},{"id":92013440,"identity":"130b185a-ee59-4cdc-90d7-f71427f03ba1","added_by":"auto","created_at":"2025-09-23 16:04:43","extension":"docx","order_by":3,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":14483,"visible":true,"origin":"","legend":"","description":"","filename":"Table1.docx","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/fc54ee68f018e438a760ed44.docx"},{"id":92012826,"identity":"cf96d0e1-c40d-42e8-93e0-9220a0473dae","added_by":"auto","created_at":"2025-09-23 15:56:43","extension":"tif","order_by":4,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":2138840,"visible":true,"origin":"","legend":"","description":"","filename":"Figure3.tif","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/076b41a2a4acafb790b0b46e.tif"},{"id":92012824,"identity":"a1dc3408-5f36-4ed5-a50b-1d771f77e73a","added_by":"auto","created_at":"2025-09-23 15:56:43","extension":"json","order_by":5,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":7630,"visible":true,"origin":"","legend":"","description":"","filename":"59c09c906ac84318868ff362cc091620.json","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/7610a3fff6d48f1783f3c4a6.json"},{"id":92012825,"identity":"cd1c13e6-b603-4b72-8bd9-68d996a0096f","added_by":"auto","created_at":"2025-09-23 15:56:43","extension":"xml","order_by":6,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":72136,"visible":true,"origin":"","legend":"","description":"","filename":"59c09c906ac84318868ff362cc0916201enriched.xml","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/5e1456cb48e4f0db87b60120.xml"},{"id":92012837,"identity":"fb6eebfb-6959-4d0a-bae8-023f30f681a2","added_by":"auto","created_at":"2025-09-23 15:56:43","extension":"tif","order_by":7,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":16945172,"visible":true,"origin":"","legend":"","description":"","filename":"Figure1.tif","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/cc9c9e3cca7045a88e24e825.tif"},{"id":92012838,"identity":"dc9524b8-9b7b-4677-803d-7ea1a785439d","added_by":"auto","created_at":"2025-09-23 15:56:43","extension":"tif","order_by":8,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":5272914,"visible":true,"origin":"","legend":"","description":"","filename":"Figure2.tif","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/7975d6c832443844dff5b80a.tif"},{"id":92012831,"identity":"90d5465a-da2a-4af2-bbf3-e216e9d7798e","added_by":"auto","created_at":"2025-09-23 15:56:43","extension":"tif","order_by":9,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":2138840,"visible":true,"origin":"","legend":"","description":"","filename":"Figure3.tif","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/b4eb2e52490241427f03c9d4.tif"},{"id":92012833,"identity":"1522c65e-b41f-4a53-8363-ed11f805e41f","added_by":"auto","created_at":"2025-09-23 15:56:43","extension":"png","order_by":10,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":1768117,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure1.png","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/f8e06c8c2c4785c82efb6ddd.png"},{"id":92012828,"identity":"b9ea98af-62be-403d-a8db-8dc26710821a","added_by":"auto","created_at":"2025-09-23 15:56:43","extension":"png","order_by":11,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":667684,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure2.png","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/81f09096c5cb738997d7b0f2.png"},{"id":92014408,"identity":"717aeb4e-25ed-4a86-ade3-7adfea62d6b1","added_by":"auto","created_at":"2025-09-23 16:12:43","extension":"png","order_by":12,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":289773,"visible":true,"origin":"","legend":"","description":"","filename":"OnlineFigure3.png","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/fce5656c771f28922fbfb497.png"},{"id":92013441,"identity":"b85bd35b-7859-4eac-b817-d70aabc59b60","added_by":"auto","created_at":"2025-09-23 16:04:43","extension":"xml","order_by":13,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":70031,"visible":true,"origin":"","legend":"","description":"","filename":"59c09c906ac84318868ff362cc0916201structuring.xml","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/d2b099426126d43ec15bd9d5.xml"},{"id":92012829,"identity":"39d248d0-9728-4206-b420-3f9693af5f63","added_by":"auto","created_at":"2025-09-23 15:56:43","extension":"html","order_by":14,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":77242,"visible":true,"origin":"","legend":"","description":"","filename":"earlyproof.html","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1/7456d33e77057437e45be524.html"},{"id":101152471,"identity":"2e51f638-c4a2-4cc7-a770-9c5644ae9720","added_by":"auto","created_at":"2026-01-26 16:11:54","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1428713,"visible":true,"origin":"","legend":"","description":"","filename":"ManuscriptHCBNocodefields.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7575209/v1_covered_c3c4502a-ddc4-48ed-a563-d841bc14c428.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Validation and Performance Assessment of a Commercial Anti-Peroxidasin Antibody","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"histochemistry-and-cell-biology","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"hacb","sideBox":"Learn more about [Histochemistry and Cell Biology](http://link.springer.com/journal/418)","snPcode":"418","submissionUrl":"https://submission.nature.com/new-submission/418/3","title":"Histochemistry and Cell Biology","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"Springer Hybrid","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"Antibodies, Immunofluorescence, Human Kidney Biopsies, Kidney Fibroblasts","lastPublishedDoi":"10.21203/rs.3.rs-7575209/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7575209/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"Peroxidasin (PXDN) is a multidomain heme peroxidase that catalyzes sulfilimine crosslinks in type IV collagen, a reaction essential for basement membrane stability. In addition to its structural role, PXDN has been implicated in oxidative stress regulation, fibrosis, and tumorigenesis. Antibody-based detection is critical for defining PXDN expression and localization, yet few commercial reagents have been rigorously validated, limiting reproducibility. Here, we assessed the specificity and performance of a commercially available anti-PXDN antibody (Abbexa, abx101906) in immunofluorescence applications. Validation was performed in formalin-fixed, paraffin-embedded human kidney tissue and a primary kidney fibroblast line under PXDN silencing and overexpression conditions. The antibody yielded reproducible labeling patterns and demonstrated specificity across cellular contexts. These findings establish abx101906 as a reliable tool for immunofluorescence-based detection of PXDN. This validation provides a foundation for future studies of PXDN biology in kidney development, disease, and potential therapeutic targeting.","manuscriptTitle":"Validation and Performance Assessment of a Commercial Anti-Peroxidasin Antibody","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-09-23 15:56:38","doi":"10.21203/rs.3.rs-7575209/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2025-10-16T15:20:52+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-10-10T13:15:50+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-10-08T19:02:43+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-09-24T17:10:04+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"196960806369780152197478855343737831823","date":"2025-09-20T13:54:14+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"264699887691029009700645076655548615628","date":"2025-09-17T14:56:11+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"144817257377561152194073007094253290725","date":"2025-09-16T07:35:45+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"263791656954893923157925577749278285975","date":"2025-09-15T17:48:42+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2025-09-15T13:26:09+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2025-09-11T07:26:39+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2025-09-10T03:58:48+00:00","index":"","fulltext":""},{"type":"submitted","content":"Histochemistry and Cell Biology","date":"2025-09-09T15:00:26+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"histochemistry-and-cell-biology","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"hacb","sideBox":"Learn more about [Histochemistry and Cell Biology](http://link.springer.com/journal/418)","snPcode":"418","submissionUrl":"https://submission.nature.com/new-submission/418/3","title":"Histochemistry and Cell Biology","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"Springer Hybrid","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"2b4cfb6d-935d-40a5-a6d5-10055c6352de","owner":[],"postedDate":"September 23rd, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[],"tags":[],"updatedAt":"2026-01-26T16:06:49+00:00","versionOfRecord":{"articleIdentity":"rs-7575209","link":"https://doi.org/10.1007/s00418-025-02453-7","journal":{"identity":"histochemistry-and-cell-biology","isVorOnly":false,"title":"Histochemistry and Cell Biology"},"publishedOn":"2026-01-21 15:58:30","publishedOnDateReadable":"January 21st, 2026"},"versionCreatedAt":"2025-09-23 15:56:38","video":"","vorDoi":"10.1007/s00418-025-02453-7","vorDoiUrl":"https://doi.org/10.1007/s00418-025-02453-7","workflowStages":[]},"version":"v1","identity":"rs-7575209","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7575209","identity":"rs-7575209","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.